Get started
AFFIMED N V COM EUR0.1 (POST REV SPLIT)AFFIMED N V COM EUR0.1 (POST REV SPLIT)AFFIMED N V COM EUR0.1 (POST REV SPLIT)

AFFIMED N V COM EUR0.1 (POST REV SPLIT)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

0HL9 chart


Full chart

0HL9 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪14.23 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.640 USD
Net income (FY)
‪−114.53 M‬ USD
Revenue (FY)
‪8.95 M‬ USD
Shares float
‪13.02 M‬
Beta (1Y)
2.61

Employees


Employees (FY)
78
Change (1Y)
−150 −65.79%
Revenue / Employee (1Y)
‪114.70 K‬ USD
Net income / Employee (1Y)
‪−1.47 M‬ USD

About Affimed N.V.


Sector
Health Technology
Industry
Biotechnology
CEO
Shawn M. Leland
Website
affimed.com
Headquarters
Mannheim
Founded
2000
ISIN
NL0015001ZQ0
FIGI
BBG00K1ZKCW2
Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

0HL9 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as 0HL9.

Frequently Asked Questions


The current price of 0HL9 is 0.950 USD — it has increased by 17.30% in the past 24 hours. Watch AFFIMED N V COM EUR0.1 (POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange AFFIMED N V COM EUR0.1 (POST REV SPLIT) stocks are traded under the ticker 0HL9.
0HL9 stock has risen by 31.50% compared to the previous week, the month change is a 7.04% rise, over the last year AFFIMED N V COM EUR0.1 (POST REV SPLIT) has showed a −79.39% decrease.
0HL9 reached its all-time high on Apr 28, 2021 with the price of 115.600 USD, and its all-time low was 0.550 USD and was reached on Apr 7, 2025. View more price dynamics on 0HL9 chart.
See other stocks reaching their highest and lowest prices.
0HL9 stock is 17.53% volatile and has beta coefficient of 2.61. Track AFFIMED N V COM EUR0.1 (POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is AFFIMED N V COM EUR0.1 (POST REV SPLIT) there?
Today AFFIMED N V COM EUR0.1 (POST REV SPLIT) has the market capitalization of ‪14.23 M‬, it has increased by 17.93% over the last week.
Yes, you can track AFFIMED N V COM EUR0.1 (POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
AFFIMED N V COM EUR0.1 (POST REV SPLIT) is going to release the next earnings report on May 21, 2025. Keep track of upcoming events with our Earnings Calendar.
0HL9 net income for the last quarter is ‪−16.63 M‬ USD, while the quarter before that showed ‪−16.63 M‬ USD of net income which accounts for 0.016% change. Track more AFFIMED N V COM EUR0.1 (POST REV SPLIT) financial stats to get the full picture.
No, 0HL9 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 28, 2025, the company has 78 employees. See our rating of the largest employees — is AFFIMED N V COM EUR0.1 (POST REV SPLIT) on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AFFIMED N V COM EUR0.1 (POST REV SPLIT) EBITDA is ‪−76.44 M‬ USD, and current EBITDA margin is ‪−1.32 K‬%. See more stats in AFFIMED N V COM EUR0.1 (POST REV SPLIT) financial statements.
Like other stocks, 0HL9 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AFFIMED N V COM EUR0.1 (POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AFFIMED N V COM EUR0.1 (POST REV SPLIT) technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AFFIMED N V COM EUR0.1 (POST REV SPLIT) stock shows the sell signal. See more of AFFIMED N V COM EUR0.1 (POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.